Neurogene NGNE
NASDAQ NGNE
$27.89 -0.50 (-1.76%)
As of: Sep 30, 2026 · 3:21 PM EDT

Neurogene (NGNE) Debt Ratio (2013)

Updated

Neurogene's (NGNE) Debt Ratio was 0.15 for Q4 2013.

Analysis

Neurogene (NGNE) Debt Ratio (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Neurogene 640.25 Mn 640.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 0.15
API Access

Neurogene Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NGNE&period=max&api_key=YOUR_API_KEY